Capital International Investors
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 1562230
Los Angeles, CA
Position in XENE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$142,548,530
-$12,986,845 QoQ
Shares Held
2,361,639
-11.7% QoQ
Ownership
2.44%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#9
of 313 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International Investors holds $7,948,137,729 across 16 Biotechnology names. XENE ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,695,144 | $2,332,218,879 | |
| 2 | RPRX |
Royalty Pharma plc
|
35,273,770 | $1,977,800,283 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
4,210,221 | $1,199,786,678 | |
| 4 | INSM |
INSMED Inc
|
8,238,124 | $878,348,780 | |
| 5 | ASND |
Ascendis Pharma A/S
|
1,988,614 | $530,403,126 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
2,361,639 | $142,548,530 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
2,963,410 | $139,398,806 | |
| 8 | COAG |
Hemab Therapeutics Holdings, Inc.
|
3,603,876 | $132,370,365 |
All Filings in XENE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $142,548,530 | 2,361,639 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $155,535,375 | 2,674,727 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $153,058,462 | 3,414,959 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $127,736,943 | 3,181,493 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $99,582,483 | 3,181,549 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $103,626,891 | 3,088,730 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $99,850,632 | 2,547,210 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $101,620,741 | 2,581,172 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $96,533,742 | 2,475,859 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $106,585,729 | 2,475,859 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $113,108,758 | 2,455,683 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $83,583,371 | 2,446,820 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $89,396,653 | 2,321,991 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $83,104,057 | 2,321,991 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $82,786,399 | 2,099,579 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $59,294,538 | 1,642,508 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $48,139,893 | 1,582,508 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $26,543,839 | 868,297 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $32,980,880 | 1,055,726 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,131,493 | 1,055,726 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,657,618 | 1,055,726 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $18,897,495 | 1,055,726 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $16,237,065 | 1,055,726 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $11,686,886 | 1,055,726 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,238,804 | 1,055,726 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $11,971,932 | 1,055,726 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||